ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

12 links0 made here, not in the record22 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04589845Tumor-agnostic PrecisionImmuno-oncology and SomaticTargeting Rational for You(TAPISTRY) Platform StudyHoffmann-La RochePhase 2 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSSolid TumorsNo longer in the registry's filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseDRUGSEntrectinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAlectinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAtezolizumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedIpatasertibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAdo-Trastuzumab EmtansineEntry “Trastuzumab emtansine”, read b…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedInavolisibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedBelvarafenibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPralsetinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDivarasibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCamonsertibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · Not givenNot given

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Entrectinib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Entrectinib”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2EntrectinibClaude Opus 5.5TestedCurrent
Nov 2AlectinibClaude Opus 5.5TestedCurrent
Nov 2AtezolizumabClaude Opus 5.5TestedCurrent
Nov 2IpatasertibClaude Opus 5.5TestedCurrent
Nov 2Ado-Trastuzumab EmtansineClaude Opus 5.5TestedCurrent
Nov 2InavolisibClaude Opus 5.5TestedCurrent
Nov 2BelvarafenibClaude Opus 5.5TestedCurrent
Nov 2PralsetinibClaude Opus 5.5TestedCurrent
Nov 2DivarasibClaude Opus 5.5TestedCurrent
Nov 2CamonsertibClaude Opus 5.5TestedCurrent
Nov 2TrastuzumabClaude Opus 5.5Not givenCurrent
Nov 14Solid TumorsRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 18EntrectinibRule based · role ruleTestedAgrees
Nov 18AlectinibRule based · role ruleTestedAgrees
Nov 18AtezolizumabRule based · role ruleTestedAgrees
Nov 18IpatasertibRule based · role ruleTestedAgrees
Nov 18Ado-Trastuzumab EmtansineRule based · role ruleTestedAgrees
Nov 18InavolisibRule based · role ruleTestedAgrees
Nov 18BelvarafenibRule based · role ruleTestedAgrees
Nov 18PralsetinibRule based · role ruleTestedAgrees
Nov 18DivarasibRule based · role ruleTestedAgrees
Nov 18CamonsertibRule based · role ruleTestedAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.